Canada markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
10.38+0.11 (+1.07%)
At close: 04:00PM EST
10.36 -0.02 (-0.19%)
After hours: 07:49PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close10.27
Bid0.00 x 800
Ask0.00 x 3100
Day's Range10.18 - 10.52
52 Week Range6.78 - 11.45
Avg. Volume9,977,924
Market Cap11.528B
Beta (5Y Monthly)1.19
PE Ratio (TTM)N/A
EPS (TTM)-0.56
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 27, 2017
1y Target Est10.00
  • Zacks

    Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Motley Fool

    Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?

    Shareholders of Catalyst Pharmaceuticals (NASDAQ: CPRX) got a nasty shock on Jan. 23 when the company reported that a competitor, Teva Pharmaceutical Industries (NYSE: TEVA), was planning to make a generic version of its only marketed drug, Firdapse. With Catalyst's shares falling 30% in a day before slightly recovering, it's clear that the market is interpreting Teva's actions as severely threatening, and it's reasonable for investors to wonder if it's time to start looking for the door. First, let's take a moment to understand what Firdapse means for Catalyst Pharmaceuticals.

  • Zacks

    Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More

    Updates from bluebird (BLUE) and Catalyst Pharmaceuticals (CPRX) are the key highlights from the biotech sector during the past week.